The European Society for Medical Oncology (ESMO) was held virtually from September 16-21, 2021. Links to MBC-related news from this conference are found below.

HER2-Positive Metastatic Breast Cancer

• Breastcancer.org: Enhertu Dramatically More Effective Than Kadcyla as Second Treatment for Metastatic HER2-Positive Breast Cancer

Hormone-Positive Metastatic Breast Cancer

• EMSO Daily Reporter: Early CDK4/6 inhibitors are not inferior to chemotherapy in HR+/HER2- metastatic breast cancer

Triple-Negative Metastatic Breast Cancer

• BreastCancer.org: Keytruda Added to Chemotherapy Improves Overall Survival for Metastatic PD-L1-Positive, Triple-Negative Breast Cancer

Tags:HER2Hormone Receptor PositiveTNBCConference Talk